Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis ...Middle East

SAN FRANCISCO and SUZHOU, China, Dec. 22, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other...

Hence then, the article about innovent announces nmpa granted new indication approvals for sulinno adalimumab injection for the treatment of pediatric plaque psoriasis and non infectious uveitis was published today ( Wednesday 23/12/2020 - 08:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis )

Also on site :

• Walmart on Dewey Avenue in Greece closed to the public Thursday afternoon
• Vinyl Collectors Will Love Amazon’s ‘Attractive’ Retro 9-Tier Record Player Stand 
• Carlos Puyol, David Villa & more in attendance for Spain vs Austria 2026 FIFA World Cup clash